MAP2K7罕见变异与中国南方和东部人群COPD风险增加相关
该研究在中国南方和东部人群中开展两阶段回顾性研究,纳入1791例COPD患者和1940例对照,检测MAP2K7五个罕见变异与COPD易感性及肺功能的关系。发现p.Glu116Lys罕见变异与COPD风险显著相关,携带者肺功能指标更低,提示其可作为中国人群COPD易感性的遗传生物标志物。
要点
- MAP2K7 p.Glu116Lys罕见变异与中国南方和东部人群COPD风险增加显著相关。
- 携带116Lys变异者较Glu/Glu野生型者pre-FEV1和pre-FEV1/FVC更低。
- 其他四个MAP2K7罕见变异与COPD风险及肺功能无显著关联。
核心结论
- MAP2K7 p.Glu116Lys罕见变异使其携带者易患COPD,可作为中国人群COPD易感性的遗传生物标志物。
研究设计与样本
- 两阶段回顾性研究,共纳入1791例COPD患者和1940例对照,人群来自中国南方和东部。
- 检测MAP2K7五个罕见变异(p.Glu116Lys、p.Asn118Ser、p.Arg138Cys、p.Ala195Thr、p.Leu259Phe)与COPD易感性的关联,并评估其对肺功能的影响。
主要发现
- 与Glu/Glu野生型相比,携带116Lys罕见变异(Lys/Glu+Lys/Lys)者COPD风险增加(OR=3.83,95%CI:2.64-5.56;P=1.45×10-12)。
- 携带116Lys罕见变异者pre-FEV1低于Glu/Glu基因型者(1.74±0.70 vs 2.00±0.68;P=3.97×10-5)。
- 携带116Lys罕见变异者pre-FEV1/FVC低于Glu/Glu基因型者(0.68±0.14 vs 0.75±0.12;P=2.40×10-10)。
- 其他罕见变异与COPD风险或肺功能均无显著关联。
临床怎么用
- 在中国南方和东部人群中,检测MAP2K7 p.Glu116Lys罕见变异可能有助于识别COPD易感个体。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: A wide range of common loci have been extensively screened and evaluated for their associations with various complex diseases; however, the relevance of rare variants causing missense substitutions in the protein-coding genes in human diseases is still poorly understood. METHODS: In this study, we conducted a two-stage retrospective study of a total of 1791 patients with COPD and 1940 controls in southern and eastern Chinese to test relevancies of five rare variants (i.e. p.Glu116Lys, p.Asn118Ser, p.Arg138Cys, p.Ala195Thr and p.Leu259Phe) of human mitogen-activated protein kinase kinase 7 (MAP2K7) to COPD susceptibility. The effects of these loci on lung function were further estimated. RESULTS: The p.Glu116Lys rare variant had significant associations with COPD risk. Compared to individuals with Glu/Glu wild-genotype, those with 116Lys rare variants (Lys/Glu+Lys/Lys) had an increased risk of COPD (OR = 3.83, 95% CI: 2.64-5.56; P = 1.45 × 10-12 ). Meanwhile, the carriers with 116Lys rare variants (Lys/Glu+Lys/Lys) had lower pre-forced expiratory volume in 1 s (pre-FEV1 : 1.74 ± 0.70 vs 2.00 ± 0.68; P = 3.97 × 10-5 ) and lower pre-FEV1 to pre-forced vital capacity ratio (pre-FEV1 /FVC: 0.68 ± 0.14 vs 0.75 ± 0.12; P = 2.40 × 10-10 ) than those with Glu/Glu genotype. However, for other rare variants, no significant association with either COPD risk or lung function was observed. CONCLUSION: Our data strongly suggest that the p.Glu116Lys rare variant in MAP2K7 predisposes its carriers to develop COPD, which would provide a useful genetic biomarker for COPD susceptibility in Chinese.
引用
- Qiu F, Li Y, Lu X, et al. Rare variant of MAP2K7 is associated with increased risk of COPD in southern and eastern Chinese. Respirology. 2017. PMID: 28120412. doi:10.1111/resp.12976
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。